Through IHC experiments and cultured cell experiments, it is proved that the decreased expression of KCNQ4 in breast cancer can inhibit proliferation, migration, invasion and promote apoptosis of tumor cells, indicating its potential as a target for cancer therapy. Here, KCNQ4 is linked to breast cancer.